Global Venous Stents Market Size To Exceed USD 3.05 Billion By 2033: Market Study Report

RELEASE DATE: May 2025 Author: Spherical Insights
The Global Venous Stents Market Size is Expected to Grow from USD 1.5 Billion in 2023 to USD 3.05 Billion by 2033, at a CAGR of 7.35% during the forecast period 2023-2033

Table of Contents

Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis


Related Topics

Night Creams Market Size Beard Oil Market Size Organic Makeup Remover Market Size Baby Toiletries Market Size

Global Venous Stents Market Size To Exceed USD 3.05 Billion By 2033 

According to a research report published by Spherical Insights & Consulting, The Global Venous Stents Market Size is Expected to Grow from USD 1.5 Billion in 2023 to USD 3.05 Billion by 2033, at a CAGR of 7.35% during the forecast period 2023-2033.          

 

Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Venous Stents Market Size, Share, and COVID-19 Impact Analysis, By Technology (Iliac Vein Stent Technology, Wallstent Technology, and Others), By Indication (Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Nutcracker Syndrome, Hemodialysis / Arteriovenous Fistulae, and Others), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

 

The venous stents market is used to define that portion of the medical devices sector that specializes in the designing, producing, distributing, and selling of venous stents intended for deployment within the venous system. Such devices are largely applied to treat venous obstructions and conditions of insufficiency, such as deep vein thrombosis, chronic venous insufficiency, and iliac vein compression syndrome. Furthermore, the market for venous stents is encouraged by the increasing incidence of chronic venous diseases, the expanding geriatric pool, technological upgrades in stent technology, and awareness of less invasive procedures. The increase in deep vein thrombosis cases, enhanced medical infrastructure, and favorable reimbursement plans also drive growth in the market. The pressure for improved vascular care continues to drive innovation and adoption. However, the high costs, limited reimbursement policies, procedural complications, stringent regulatory approvals, lack of awareness, skilled professionals shortage, alternative treatments, and risks such as restenosis and thrombosis hinder the growth of the global venous stents market and are key restraints for the growth of the market.

 

The iliac vein stent technology segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.              

On the basis of the technology, the global venous stents market is divided into iliac vein stent technology, wallstent technology, and others. Among these, the iliac vein stent technology segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to the rising cases of deep vein thrombosis (DVT) and chronic venous insufficiency, increasing adoption of minimally invasive procedures, technological advancements, and favorable reimbursement policies. Growing awareness and demand for effective venous outflow restoration are expected to drive significant CAGR growth.

 

The May-Thurner syndrome segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.           

On the basis of the indication, the global venous stents market is divided into chronic deep vein thrombosis, post-thrombotic syndrome, May-Thurner syndrome, nutcracker syndrome, hemodialysis / arteriovenous fistulae, and others. Among these, the May-Thurner syndrome segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segmental growth is attributed to its rising diagnosis rates, increasing awareness, and growing preference for venous stenting as the primary treatment. Advancements in stent technology, a higher prevalence of iliac vein compression, and favorable reimbursement policies are expected to drive its significant CAGR growth in the forecast period.

 

The hospitals segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period.

On the basis of the end-user, the global venous stents market is categorized into hospitals, ambulatory surgical centers, specialty centers, and others. Among these, the hospitals segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period. The segmental growth is attributed to the availability of advanced medical infrastructure, skilled professionals, and a high volume of venous stenting procedures. Increasing hospital admissions for venous disorders, favorable reimbursement policies, and growing investments in healthcare facilities are expected to drive substantial CAGR growth during the forecast period.

 

North America is projected to hold the largest share of the global venous stents market over the forecast period.

North America is projected to hold the largest share of the global venous stents market over the forecast period. The segmental growth is attributed to a high prevalence of venous disorders, advanced healthcare infrastructure, increasing adoption of minimally invasive procedures, and strong reimbursement policies. Additionally, the presence of key market players, ongoing technological advancements, and rising awareness about venous diseases further contribute to market growth in the region.

 

Asia Pacific is expected to grow at the fastest CAGR growth of the global venous stents market during the forecast period. The segmental growth is attributed to the increasing healthcare investments, a rising prevalence of venous diseases, and growing awareness of minimally invasive treatments. Expanding medical infrastructure, improving reimbursement policies, and a surge in aging populations further drive demand for venous stents, fostering rapid market expansion in the region.

 

Company Profiling

Major vendors in the global venous stents market are Philips N.V., Medtronic plc, Optimed Medizinische Instrumente GmbH, Plus Medica GmbH & Co. KG, SUZHOU INNOMED MEDICAL DEVICE CO., Ltd., W. L. Gore & Associates, Inc., and others.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Recent Development

  • In October 2023, Philips revealed the findings of the VIVID trial, which assessed the Duo venous stent system's effectiveness and safety.  A multicenter, single-arm study called the VIVID trial recruited 162 patients from 30 sites in the US and Poland who had clinically significant venous outflow obstruction that was either non-thrombotic, acute thrombotic, or chronic post-thrombotic.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global venous stents market based on the below-mentioned segments: 

 

Global Venous Stents Market, By Technology

  • Iliac Vein Stent Technology
  • Wallstent Technology
  • Others

 

Global Venous Stents Market, By Indication

  • Chronic Deep Vein Thrombosis
  • Post Thrombotic Syndrome
  • May-Thurner Syndrome
  • Nutcracker Syndrome
  • Hemodialysis / Arteriovenous Fistulae
  • Others

 

Global Venous Stents Market, By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Centers
  • Others

 

 Global Venous Stents Market, By Regional

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Recent Insights


Your personal details are safe with us, Privacy Policy.

Thank You!

We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.

+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com

We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies